ADMA BIOLOGICS, INC. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Adma Biologics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Adma Biologics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 236M shares, a 4.61% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 236M +10.4M +4.61% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 233M +8.5M +3.79% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 232M +9.51M +4.28% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 226M +4.25M +1.91% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 226M +29.2M +14.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 225M +28.2M +14.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 222M +25.9M +13.2% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 222M +26M +13.3% Dec 31, 2022 10-K 2024-02-28
Q3 2022 197M +58.5M +42.3% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 196M +64.5M +48.9% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 196M +73.3M +59.6% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 196M +90.9M +86.7% Dec 31, 2021 10-K 2023-03-23
Q3 2021 138M +48.7M +54.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 132M +45.5M +52.7% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 123M +36.7M +42.5% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 105M +45.6M +76.8% Dec 31, 2020 10-K 2022-03-24
Q3 2020 89.6M +30.3M +51.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 86.3M +27M +45.6% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 86.3M +40M +86.3% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 59.3M +13M +28% Dec 31, 2019 10-K 2021-03-25
Q3 2019 59.3M +13M +28% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 59.3M +13M +28% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 46.4M +9.63M +26.2% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 46.4M +9.63M +26.2% Dec 31, 2018 10-K 2020-03-13
Q3 2018 46.4M +29.1M +169% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 46.3M +29.2M +170% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 36.7M +23.8M +185% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 36.7M +23.8M +185% Dec 31, 2017 10-K 2019-03-13
Q3 2017 17.2M +4.32M +33.5% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 17.2M +4.3M +33.3% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 12.9M +2.17M +20.3% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 12.9M +2.17M +20.3% Dec 31, 2016 10-K 2018-03-29
Q3 2016 12.9M +2.17M +20.3% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 12.9M +2.18M +20.4% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 10.7M +7.51K +0.07% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 10.7M +1.42M +15.3% Dec 31, 2015 10-K 2017-02-24
Q3 2015 10.7M +1.42M +15.3% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 10.7M +1.41M +15.2% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 10.7M +1.41M +15.2% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 9.29M 0 0% Dec 31, 2014 10-K 2016-03-23
Q3 2014 9.29M +3.42M +58.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 9.29M +3.42M +58.3% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 9.29M +3.42M +58.3% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 9.29M +3.42M +58.3% Dec 31, 2013 10-K 2015-03-09
Q3 2013 5.87M +1.22M +26.1% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 5.87M +1.22M +26.1% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 5.87M +1.22M +26.1% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 5.87M +5.46M +1337% Dec 31, 2012 10-K 2014-03-28
Q3 2012 4.65M +2.15M +86.2% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 4.65M +2.15M +86.2% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 4.65M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 409K Dec 31, 2011 10-K 2013-03-06
Q3 2011 2.5M Sep 30, 2011 10-Q 2011-10-28
Q2 2011 2.5M Jun 30, 2011 10-Q 2012-02-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.